Nirmatrelvir-Ritonavir Effective for Outpatient Treatment of COVID-19
Reduces 30-day risk for hospitalization and death, while only death was reduced in association with molnupiravir
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.